Hyperthyroidism and cerebral venous thrombosis

European Neurology

Volumn 54, Issue 2, 2005, Pages 78-80

  Mouton, S ^a   Nighoghossian, N ^a   Berruyer, M ^a   Derex, L ^a   Philippeau, F ^a   Cakmak, S ^a   Honnorat, J ^a   Hermier, M ^a   Trouillas, P ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Cerebral venous thrombosis; Factor VIII; Thyrotoxicosis

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 8; HEPARIN;

ADULT; ARTICLE; BLOOD CLOTTING TEST; CASE REPORT; CEREBRAL VENOUS THROMBOSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; THYROID FUNCTION;

FACTOR VIII; FEMALE; HUMANS; HYPERTHYROIDISM; INTRACRANIAL THROMBOSIS; MIDDLE AGED;

EID: 27544510745     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087717     Document Type: Article

References (16)

1. Ameri A, Bousser M: Cerebral venous thrombosis. Neurol Clin 1992;10:87-111.
2. Verberne HJ, Fliers E, Prummel MF, Stam J, Brandjes DP, Wiersinga WM: Thyrotoxicosis as a predisposing factor for cerebral venous thrombosis. Thyroid 2000;10:607-610.
3. Dulli DA, Luzzio CC, Williams EC, Schutta HS: Cerebral venous thrombosis and activated protein C resistance. Stroke 1996;27:1731-1733.
4. Coller KM, Ratliff DM, Burge MR: Potential association of thyrotoxicosis with vitamin B and folate deficiencies, resulting in risk for hyperhomocysteinemia and subsequent thromboembolic events. Endocr Pract 2003;9:290-295.
5. Cakmak S, Derex L, Berruyer M, Nighoghossian N, Philippeau F, Adeleine P, Hermier M, Froment JC, Trouillas P: Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology 2003;60:1175-1178.
6. Karouache A, Mounach J, Bouraza A, Ouahabi H, Reda R, Boutaleb N, Mossadaq R: Cerebral thrombophlebitis revealing hyperthyroidism: two cases report and literature review (in French). Rev Med Interne 2004;25:920-923.
7. Maes J, Michotte A, Velkeniers B, Stadnik T, Jochmans K: Hyperthyroidism with increased factor VIII procoagulant protein as a predisposing factor for cerebral venous thrombosis. J Neurol Neurosurg Psychiatry 2002;73:458.
8. Molloy E, Cahill M, O'Hare JA: Cerebral venous sinus thrombosis precipitated by Graves' disease and factor V Leiden mutation. Ir Med J 1993;96:46-47.
9. Page SR, Scott AR: Thyroid storm in a young woman resulting in bilateral basal ganglia infarction. Postgrad Med J 1993,69:813-831.
10. Ra CS, Lui CC, Liang CL, Chen HJ, Kuo YL, Chen WF: Superior sagittal sinus thrombosis induced by thyrotoxicosis: case report. J Neurosurg 2001;94:130-132.
11. Siegert CE, Smelt AH, de Bruin TW: Superior sagittal sinus thrombosis and thyrotoxicosis: possible association in two cases. Stroke 1995;26:496-497.
12. Erem C, Ersoz HO, Karti SS, Ukinc K, Hacihasanoglu A, Deger O, Telatar M: Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 2002;25:345-350.
13. Schambeck CM, Hinney K, Haubitz I, Mansouri Taleghani B, Wahler D, Keller F: Familial clustering of high factor VIII levels in patients with venous thromboembolism. Arterioscler Thromb Vasc Biol 2001;21:289-292.
14. Soria JM, Almasy L, Souto JC, Buil A, Martinez-Sanchez E, Mateo J, Borrell M, Stone WH, Lathrop M, Fontcuberta J, Blangero J: A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility. Blood 2003;101:163-167.
15. Kamphuisen PW, Eikenboom JCJ, Bertina RM: Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 2001;21:731-738.
16. Rosendaal FR, Helmerhorst M, Vandenbroucke JP: Oral contraceptives, hormone replacement therapy and thrombosis. Thromb Haemost 2001;86:112-123.